EGFR and hTERT expression in high risk COPD patients – clinical application

R. Cherneva, O. Georgiev, D. Petrova, D. Petrov, D. Toncheva (Sofia, Bulgaria)

Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Session: Biological and clinical markers in lung cancer
Session type: Thematic Poster Session
Number: 2674
Disease area: Thoracic oncology

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
R. Cherneva, O. Georgiev, D. Petrova, D. Petrov, D. Toncheva (Sofia, Bulgaria). EGFR and hTERT expression in high risk COPD patients – clinical application. Eur Respir J 2009; 34: Suppl. 53, 2674

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
EGFR and hTERT mRNA expression in non-small cell lung cancer patients – Diagnostic and prognostic implications
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010


COPD prevalence in lung cancer patients – Is COPD a risk factor for lung cancer?
Source: Annual Congress 2011 - Epidemiology of lung cancer and screening
Year: 2011

Soluble NKG2D ligand expression associates with smoking, presence of COPD, and presence of lung cancer: The "EMICON" study
Source: Annual Congress 2010 - Lung morbidity on exposure to various agents
Year: 2010

IL1RL1 polymorphisms are associated with the level of soluble IL1RL1 and asthma development in children
Source: Annual Congress 2009 - Asthma genetics: from genome wide to single nucleotide polymorphisms
Year: 2009

The VE/VCO2 slope as a factor associated with the health status in patients with COPD
Source: Annual Congress 2012 - Outcomes and assessment methods in physiotherapy and rehabilitation
Year: 2012


Tissue expression of alpha crystallins and plasma levels of antibodies against them in NSCLC patients – Prognostic significance
Source: Annual Congress 2010 - Biomarkers for lung cancer
Year: 2010


Smoking, genotype and gene expression levels in COPD
Source: International Congress 2014 – Personalised exposure and gene environment interactions in chronic airway disease: the exposome and epigenome
Year: 2014



Role of -511C>T/+3953C>T haplotypes of IL1B gene as risk factors of COPD
Source: Annual Congress 2012 - Recent progress in mechanisms and diagnostics of COPD and asthma
Year: 2012


TTF-1 in advanced SCLC – Diagnostic and prognostic relevance
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

COPD screening and risk factor frequency identification study
Source: Annual Congress 2013 –Disease control and quality of life in airway diseases
Year: 2013


EGFR – a useful biomarker?
Source: Annual Congress 2009 - Biological and clinical markers in lung cancer
Year: 2009

Characteristics and prognostic relevance of p53 gene mutations in Polish non small cell lung cancer (NSCLC) patients
Source: Eur Respir J 2005; 26: Suppl. 49, 92s
Year: 2005

Impact of age in the clinical expression of COPD
Source: Annual Congress 2008 - COPD in the elderly - quality of life and scores in COPD
Year: 2008


The nuclear expression of the small heat shock protein – alpha B crystalline as a marker for poor prognosis in NSCLC patients
Source: Annual Congress 2009 - Basic science and lung cancer
Year: 2009



Inhibitor of DNA-binding (Id) – 1 and 3 proteins overexpression has impact on prognosis of lung adenocarcinoma
Source: Annual Congress 2011 - Progress in pathology of lung cancer
Year: 2011


Imbalances in TNFα in patients with a TNFα polymorphism and a COPD phenotype
Source: Annual Congress 2009 - New results in molecular pathology and functional genomics of non-neoplastic lung diseases
Year: 2009

BAMBI – A TGF-β pseudoreceptor with possible functional involvement in COPD and NTHI infection
Source: Annual Congress 2011 - Molecular: pathology of infectious and inflammatory lung disease
Year: 2011


Identifying a ‘frequent exacerbator‘ phenotype in a cohort of COPD patients (EXACO study)
Source: Annual Congress 2012 - Prevalences and characterstics of obstructive airway disease
Year: 2012


High levels of serum cholesterol – protective and predictive factor for activation of tuberculosis; practical considerations
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009

Studies on clinical significance and relationship with PI and gene protein expression of p16, Rb and Cyclin-D1 in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 230s
Year: 2002